Weekly CEO & CFO Moves – January 12, 2024

by | Jan 12, 2024

About the Weekly
Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of the CEO moves and CFO moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Special Recap: 2023 New CEO Winners & Losers

Weekly CEO & CFO Move Wrap

JetBlue (JBLU) stock price chart

 

 

 

 

 

 

 

 

JetBlue (JBLU) announced the appointment of Joanna Geraghty as its new CEO, making her the first female to lead a major American airline. Long-time CEO, Robin Hayes, is stepping down due to health reasons. Hayes oversaw a difficult run for JetBlue with it’s stock price down below $5 and over 70% since he took over. Incoming CEO Geraghty has been with JetBlue for nearly two decades and currently serves as the company’s president and COO. The CEO transition comes at an important juncture for JetBlue. It awaits a federal judge’s ruling on its proposed $3.8 billion acquisition of Spirit Airlines; is dealing with challenges arising from the recent termination of its partnership with American Airlines; and continues working to recover from pandemic-related losses.

CEO Moves

10X CAPITAL VENTURE ACQUISITION CORP III (VCXB)
Leaving: CEO – Hans Thomas ( 2.9 yrs ; 3.4% TSR)
Replaced by: David Weisburd
Mr. Weisburd has been 10X III’s Chief Operating Officer, Head of Origination and a member of the Board since February 2021. Mr. Weisburd founded the venture capital firm Growth Technology Partners in May 2015 and served as general partner until December 2019, when the firm was acquired by 10X Capital Holdings LLC (“10X Capital”). The portfolio companies of Growth T…read full bio

ACUTUS MEDICAL INC (AFIB)
Leaving: CEO – David Roman ( 1.7 yrs *interim; -62.3% TSR)
Replaced by: Takeo Mukai
Takeo Mukai. Mr. Mukai has served as our Senior Vice President, Chief Financial Officer since January 2023. Mr. Mukai previously served as the Company’s interim Chief Financial Officer since August 2022 and as Vice President, Finance from July 2021 to August 2022. Prior to his service with the Company, Mr. Mukai served in various roles of increasing responsibility with Medtronic, Inc. from 2007 to…read full bio

CALAMP CORP (CAMP)
Leaving: CEO – Jason Cohenour ( .4 yrs *interim; -73.5% TSR)
Replaced by: Christopher R. Adams
Mr. Adams currently serves as VP/GM of the Automotive Sensing Division of onsemi, a semiconductor manufacturing company, a position he has held since May 2020. Prior to onsemi, from October 2019 to May 2020, Mr. Adams served as the Chief Operating Officer at SafeAI, an autonomous mining and construction company. From September 2015 to October 2019, Mr. Adams served as a General Manager of BAE Syst…read full bio

COMPASS THERAPEUTICS INC (CMPX)
Leaving: CEO – Thomas J Schuetz ( 3.6 yrs ; -30.0% TSR)
Replaced by: Vered Bisker-Leib
Vered Bisker-Leib, Ph.D., M.B.A. President and Chief Operating Officer 2017 52 Vered Bisker-Leib, Ph.D., M.B.A., has served as our President and Chief Operating Officer since August 2020 . Dr. Bisker-Leib joined Compass Therapeutics LLC in 2017 as Chief Business Officer bringing 20 years of corporate development, strategy, fundraising, licensing, and M&A transaction expertise gained t…read full bio

ENVESTNET INC (ENV)
Leaving: CEO – William Crager ( 4.4 yrs ; -4.1% TSR)
Replaced by (interim)James L Fox
James Fox Age 71 Mr. Fox has served as a member of our Board since February 2015 and Chair of the Board since March 2020. Mr. Fox retired as Non-Executive Chairman of FundQuest, Inc., upon its acquisition by the Company, effective December 2011 after serving in that role since September 2010 and, prior to that, as President and Chief Executive Officer starting in October 2005. Mr. Fox has over…read full bio

JETBLUE AIRWAYS CORP (JBLU)
Leaving: CEO – Robin Hayes ( 9.0 yrs ; -10.9% TSR)
Replaced by: Joanna Geraghty
Ms. Geraghty, age 51, first joined the Company in 2005. Prior to her appointment as President and Chief Operating Officer in May 2018, Ms. Geraghty served as the Company’s Executive Vice President, Customer Experience from 2014 to 2018. She also served as Executive Vice President, Chief People Officer from 2010 to 2014, after serving as Vice President and Associate General Counsel and Direct…read full bio

KEY TRONIC CORP (KTCC)
Leaving: CEO – Craig D Gates ( 15.2 yrs ; 10.6% TSR)
Replaced by: Brett R Larsen
Mr. Larsen, age 50, has served as Executive Vice President of Administration, Chief Financial Officer, and Treasurer since July 2015. Previously, he was Vice President of Finance and Controller from February 2010 to July 2015. He was Chief Financial Officer of FLSmidth Spokane, Inc. from December 2008 to February 2010. From October 2005 through November 2008, Mr. Larsen served as Controller of Key…read full bio

LIVEPERSON INC (LPSN)
Leaving: CEO – John Deneen Collins ( .4 yrs ; -25.1% TSR)
Replaced by: Anthony John Sabino
Prior to joining the Company, Mr. Sabino, age 50, served as the Senior Vice-President, Chief Customer Officer of VMware, Inc., a cloud computing and virtualization technology company, from October 2021 to January 8, 2024 (shortly after the completion of VMware’s acquisition by Broadcom). At VMware, Mr. Sabino led the company’s 7,000-person global Customer Experience and Success organiz…read full bio

ONCONETIX INC (ONCO)
Leaving: CEO – Neil Campbell ( .3 yrs )
Replaced by (interim)Ralph Schiess
Dr. Schiess co-founded Proteomedix in March 2010 and served as its Chief Executive Officer from its inception until December 2019. Dr. Schiess then served as Proteomedix’s Chief Scientific Officer from January 2020 to May 2023. Dr. Schiess returned to his role as Chief Executive Officer in June 2023 and served until the consummation of the Share Exchange. Dr. Schiess is qualified to serve as…read full bio

ORTHOFIX MEDICAL INC (OFIX)
Leaving: CEO – Catherine M Burzik ( .3 yrs *interim; )
Replaced by: Massimo Calafiore
Mr. Calafiore, 52, served as the President and Chief Executive Officer of LimaCorporate S.p.A., a global orthopedic company focused on restoring motion through digital innovation and customized hardware, from September 2022 to January 2024, when it was acquired by Enovis Corporation. Previously, Mr. Calafiore served from September 2021 through August 2022 as Executive Vice President and Chief Comm…read full bio

SOLO BRANDS INC (DTC)
Leaving: CEO – John Merris ( 2.3 yrs ; -42.0% TSR)
Replaced by: Christopher T Metz
Prior to joining the Company, Mr. Metz, age 58, served as President and Chief Executive Officer of Vista Outdoor Inc. (NYSE: VSTO), a designer, manufacturer, and marketer of outdoor sports and recreation products from October 2017 to March 2023. Prior to Vista Outdoor Inc., Mr. Metz served as President and Chief Executive Officer of Arctic Cat Inc., a manufacturer of all-terrain&nbs…read full bio

TWILIO INC (TWLO)
Leaving: CEO – Jeff Lawson ( 15.8 yrs ; 12.1% TSR)
Replaced by: Khozema Shipchandler
Mr. Shipchandler, age 49, has served as the Company’s President, Twilio Communications since March 2023. Previously, Mr. Shipchandler served as the Company’s Chief Operating Officer from 2021 to 2023 and the Company’s Chief Financial Officer from 2018 to 2021. From 2015 to 2018, Mr. Shipchandler served as Chief Financial Officer and Executive Vice President of Corp…read full bio

CFO Moves

ALLIANCEBERNSTEIN HOLDING LP (AB)
Leaving: CFO – William R Siemers ( .8 yrs *interim; -5.6% TSR)
Replaced by: Jackie Marks
Ms. Marks, age 45, joins the firm with more than 20 years of relevant experience, most recently serving as CFO of Condé Nast Publications from March 2021 to March 2023. Prior to joining Condé Nast, Ms. Marks served as CFO at Mercer from April 2018 to March 2021. Previously, she served in various leadership positions at Thompson Reuters from August 2003 to April 2018….read full bio

BIOTE CORP (BTMD)
Leaving: CFO – Samar Kamdar ( 1.4 yrs ; 15.0% TSR)
Replaced by: Robert Peterson
Mr. Peterson, age 47, joins the Company from Virbac Corp., an animal health pharmaceutical company, where he served as the chief financial officer from September 2017 to January 2024. Mr. Peterson is a Certified Public Accountant and holds a Bachelor’s in Business Administration and a Masters in Business Administration from Texas Christian University….read full bio

DUTCH BROS INC (BROS)
Leaving: CFO – Charles Jemley ( 2.4 yrs ; -17.7% TSR)
Replaced by: Joshua Guenser
Guenser joins Dutch Bros as Incoming Chief Financial Officer on or about February 19, 2024, and we expect, following a transitional period and subject to his appointment by the Board, he will succeed Charley Jemley as Chief Financial Officer following the release of the Company’s financial results for the quarter ending March 31, 2024. To facilitate a smooth transition, we expect Jemley will…read full bio

FLEXSTEEL INDUSTRIES INC (FLXS)
Leaving: CFO – Derek P Schmidt ( .7 yrs *interim; 1.2% TSR)
Replaced by: Michael J. Ressler
Mr. Ressler joined Flexsteel Industries, Inc. in 2006. Of his more than seventeen years with the Company, Mr. Ressler has spent over fourteen years in multiple positions with increasing responsibilities within the finance and accounting functions. Mr. Ressler served as the Director of Finance from 2018 through 2022. Since that time, Mr. Ressler has served as the Vice President – Manufacturin…read full bio

KEY TRONIC CORP (KTCC)
Leaving: CFO – Brett R Larsen ( 8.9 yrs ; -10.4% TSR)
Replaced by: Anthony G. Voorhees
Mr. Voorhees, age 50, has been Vice President of Finance and Controller since November 2021. Previously, he was Director of Finance and Controller from July 2019 to November 2021 and Secretary from January 2021 to January 2023. He was Senior Manager of Corporate Finance for the company since July 2015 and Manager of Financial Reporting since April 2014. Before joining Key Tronic, Mr. Voorhees work…read full bio

KNIGHTSCOPE INC (KSCP)
Leaving: CFO – Mallorie Sara Burak ( 3.3 yrs ; -79.5% TSR)
Replaced by: Apoorv Dwivedi
Apoorv S. Dwivedi has accepted the position of Executive Vice President and Chief Financial Officer of the Company, effective as of January 15, 2024, or on a mutually agreed date, and is expected to be appointed as the Company’s principal financial officer and principal accounting officer at that time. Mr. Dwivedi most recently served as the Chief Financial Officer of Nxu, Inc. from January …read full bio

NAVITAS SEMICONDUCTOR CORP (NVTS)
Leaving: CFO – Ron Shelton ( 1.8 yrs ; -4.4% TSR)
Replaced by: Janet Chou
Chou was previously Vice President and CFO of Global Operations for Western Digital Corporation, a $12 billion Nasdaq-listed developer, manufacturer, and provider of data storage devices and solutions. She was previously CFO of JCET Group Co., Ltd., a $5 billion global semiconductor company listed on the Shanghai Stock Exchange. Before that Chou progressed through a series of senior financial mana…read full bio

RACKSPACE TECHNOLOGY INC (RXT)
Leaving: CFO – Naushaza Molu ( 1.0 yrs ; -43.7% TSR)
Replaced by: Mark A Marino
Mr. Marino, age 47, joined Rackspace Technology as Vice President, Americas Chief Financial Officer in 2020 and was promoted to Chief Accounting Officer in late 2021. Prior to joining the Company, Mr. Marino served as Vice President of Finance for Acelity, a leading global medical technology company acquired by 3M, from 2015 to 2020. Prior to Acelity, Mr. Marino was Vice President, Finan…read full bio

SCHOLASTIC CORP (SCHL)
Leaving: CFO – Kenneth J Cleary ( 6.3 yrs ; 1.7% TSR)
Replaced by: Haji L. Glover
Haji Glover, age 50, brings over twenty seven years of finance and analytical experience in a variety of industry segments with both publicly traded and privately held companies. From September 2022 to January 2024, he served as Director of Finance at Amazon, New York City, responsible for leading the finance organization supporting the People Experience and Technology (PXT) division. From January…read full bio

SEASTAR MEDICAL HOLDING CORP (ICU)
Leaving: CFO – Caryl Baron ( 1.3 yrs ; -89.8% TSR)
Replaced by: David Green
Mr. Green served as Chief Financial Officer of BlackSwan Vascular, Inc. and LamaMed Solutions, Inc., related medical device development companies, from May 2021 to January 2024.  Mr. Green served as Interim Chief Financial Officer of Prolacta Biosciences, Inc., a private company providing specialized nutrition products to critically ill premature infants, from September 2021 to October 2022. …read full bio

SONOS INC (SONO)
Leaving: CFO – Eddie Lazarus ( 1.3 yrs *interim; -5.4% TSR)
Replaced by: Saori Casey
From July 2011 to December 2023, Ms. Casey, age 56, served as Vice President of Finance at Apple Inc. Prior to that, Ms. Casey held various roles as a finance executive at Cisco Systems Inc. for fifteen years. She has served on the board of directors of Houzz Inc. since 2019, and also serves as the Chair of its Audit Committee and on its Compensation Committee. Ms. Casey holds a B.A. in Economics …read full bio

Recent Analysis

Daily SPAC Update – December 10, 2024

Jackson Acquisition II $200M IPO (Jackson I Liquidated). APXI Shareholders Approve Extension w/ 5M Redemptions. HCVI Merger Amendment. SLAMF Vote Adjourned and IVCB Vote Postponed. 

Daily SPAC Update – December 9, 2024

TCHP + Coincheck Deal Approved. GLLI, INAQ, ESHA Shareholders Approve Extensions. DP Cap Acquisition  (DPCS) Dismisses Accountant. SLAM and BRKH Extension Votes.

Daily SPAC Update – December 4, 2024

Global Star (GLST) Extension Approved. APXI Extension Vote Today. ATMC Updates Trust Numbers. LATG Deal Vote Set for Dec 23. ATMV, SHAP, TRON, INAQ Set Extension Votes.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.